StockIQStockIQ.tech

Encompass Health Corporation (EHC) Stock Analysis

--

Free AI-powered analysis and research for Encompass Health Corporation stock

Sector: Healthcare

EHC snapshot

Data as of 3 Nov 2026 close. Updated daily.

Last close
136.62 USD (-0.41%)
52-week range
92.77 – 139.12
Position in range
95%
1-year change
+17.7%
Market cap (USD)
$13.5B
P/E (trailing)
21.9
RSI (14-day)
69
vs 200-day average
+23.8%
MACD
Above signal line
StockIQ score: 85/100 · Strongly positive signals

Encompass Health Corporation scores 85/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 95% of its 52-week range, up 17.7% over the past year. Latest reported figures show a profit margin of 10.0%, return on equity of 25.0% and revenue growth of +9.6%.

What is driving the score
  • Strong Uptrend: +12
  • MACD Bullish: +8
  • Good Profit Margin (10.0%): +5
  • Weak Liquidity (1.19 Current Ratio): -5
  • Excellent ROE (25.0%): +8
  • High P/B (5.38): -5
  • Strong Long-term Uptrend: +8
  • Healthy Momentum (+17.7% over 1 year): +7
  • Low Volume (0.3x): -3

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full EHC report

Encompass Health Corporation (EHC) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze EHC Now β†’

πŸ“° Latest Update

What Encompass Health Stock Guidance Raise Means For Shareholders

Encompass Health Corporation (EHC) raised its stock guidance for the upcoming quarter, signaling stronger-than-expected performance driven by increased demand for its rehabilitation services. This upward revision is significant for investors as it reflects the company's resilience in a challenging healthcare environment and suggests potential for improved profitability. Shareholders may view this as a positive indicator of the company's growth trajectory and overall financial health.

Read full article β†’

History

People also watch

MCK
McKesson Corporation
--
UNH
UnitedHealth Group Inc.
--
CVS
CVS Health Corporation
--
IBRX
ImmunityBio, Inc.
--
PODD
Insulet Corporation
--